Manufacturer
Sanofi-Aventis Deutschland GmbH
Contents
Docetaxel
Indication
Breast cancer, Gastric adenocarcinoma, Head and neck cancer, Non-small cell lung cancer, Prostate cancer.
Instruction
Administer via IV Infusion.
Drug interaction
CYP3A4 inducers, inhibitors, or substrates may alter docetaxel metabolism.
Malaysia
